Periscope Capital’s Aimei Health Technology Co Right AFJKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2K Hold
52,900
﹤0.01% 454
2026
Q1
$16.3K Hold
52,900
﹤0.01% 396
2025
Q4
$19.8K Sell
52,900
-95,600
-64% -$36K ﹤0.01% 315
2025
Q3
$47.5K Hold
148,500
0.01% 221
2025
Q2
$35.6K Hold
148,500
0.01% 184
2025
Q1
$46.4K Hold
148,500
0.02% 127
2024
Q4
$23.8K Sell
148,500
-1,500
-1% -$327 0.01% 126
2024
Q3
$34.5K Hold
150,000
0.02% 108
2024
Q2
$31.5K Hold
150,000
0.01% 166
2024
Q1
$30K Buy
+150,000
New +$29.7K 0.01% 257

Other funds holding AFJKR

Periscope Capital's AFJKR Position: Q2 2026 in Review

Periscope Capital held its Aimei Health Technology Co Right (AFJKR) position steady in Q2 2026 at 52,900 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #454.

Periscope Capital first reported a position in AFJKR in Q1 2024 and has held it in 10 quarters since. The position peaked at $47.5K in Q3 2025. 15 funds tracked by Wall St. Rank hold AFJKR as of Q2 2026.

  • Periscope Capital held 52,900 shares of Aimei Health Technology Co Right worth $12.2K as of Q2 2026.
  • Periscope Capital left its Aimei Health Technology Co Right share count unchanged in Q2 2026.
  • Aimei Health Technology Co Right made up ﹤0.01% of Periscope Capital's portfolio in Q2 2026, its #454 holding.
  • Periscope Capital first reported a position in Aimei Health Technology Co Right in Q1 2024 and has held it in 10 quarters since.
  • Periscope Capital's Aimei Health Technology Co Right position peaked at $47.5K in Q3 2025.
  • 15 funds tracked by Wall St. Rank held Aimei Health Technology Co Right as of Q2 2026.

Based on Periscope Capital's 13F filing for Q2 2026, filed 11 Aug 2026.